• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.


  1. mitoMAN

    T-Cell Modulation - Mdivi-1 and FGIN-1-27

    Two very promising treatment approaches that modulate T helper cells and have been proposed to be effective in animal models of autoimmune encephalomyelitis. Mdivi-1 also greatly works on mitochondria and DRP1 Proteins which might be toxic at too high dosages as an inhibitor. FGIN-1-27 seems...
  2. mitoMAN

    Mdivi-1 Inhibition of Drp1 (CVB and Herpes inhibition)

    Mdivi-1 Dr. Prusty has tested this Peptide to be highly effective in vitro but there have not been any studies conducted in human trials so far. Contrary to SS-31, this is not only boosting Mitochondria but also inhibitng Drp1 and other Protein Kinase aspects needed for viral reproduction of...